Organicell Regenerative Medicine, Inc.
OCEL · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11 | $12 | $31 | $58 |
| - Cash | $1 | $2 | $4 | $0 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $11 | $11 | $28 | $58 |
| Revenue | $5 | $5 | $6 | $6 |
| % Growth | 1.4% | -29.8% | 16% | – |
| Gross Profit | $4 | $4 | $6 | $5 |
| % Margin | 81.7% | 88.9% | 88.4% | 90.2% |
| EBITDA | -$5 | -$6 | -$8 | -$13 |
| % Margin | -115.1% | -133.1% | -125.8% | -226.3% |
| Net Income | -$5 | -$7 | -$9 | -$13 |
| % Margin | -101.8% | -153.3% | -137.9% | -229% |
| EPS Diluted | -0.74 | -0.99 | -1.57 | -2.42 |
| % Growth | 25.3% | 36.9% | 35.1% | – |
| Operating Cash Flow | -$1 | -$2 | -$3 | -$3 |
| Capital Expenditures | $0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$1 | -$2 | -$4 | -$3 |